Home LiteratureArticle Details
PMID: 12370399 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 169 ·No. 8 ·2002-10-15 ·Pages 4604-12

Phipps S, Ying S, Wangoo A, Ong YE, Levi-Schaffer F, Kay AB

Abstract

Several in vitro studies suggest that eosinophils may play a role in fibrosis, remodeling, and repair processes associated with IgE-mediated hypersensitivity. However, the relationship in vivo, between allergen-induced tissue eosinophilia and markers of repair has yet to be established in human atopic subjects. Using the allergen-induced cutaneous late-phase reaction as a model of allergic inflammation, we have tested the hypothesis that eosinophil-derived TGF-beta1 and IL-13 are temporarily associated with myofibroblast formation and deposition of tenascin and procollagen I. Biopsies were taken from atopic volunteers at 1, 3, 6, 24, 48, and 72 h after intradermal allergen challenge and were examined by immunohistochemistry. Following the peak of the late-phase reaction (6 h) there were persisting TGF-beta1(+) eosinophils, alpha-smooth muscle actin(+) myofibroblasts, tenascin immunoreactivity, and procollagen-I(+) cells 24-48 h postchallenge. Direct evidence of generation of repair markers was obtained by coculture of eosinophils and fibroblasts. This resulted in alpha-smooth muscle actin immunoreactivity that was inhibitable by neutralizing Abs to TGF-beta as well as production of tenascin transcripts and protein product. TGF-beta1 and IL-13 also induced tenascin expression. We conclude that TGF-beta1 and IL-13, provided partially by eosinophils, contribute to repair and remodeling events in allergic inflammation in human atopic skin.

MeSH Terms
Actins/antagonists & inhibitors Adolescent Adult Allergens/administration & dosage,immunology Biomarkers/analysis Cells, Cultured Down-Regulation/immunology Eosinophilia/immunology,metabolism,pathology Eosinophils/metabolism,pathology Female Fibroblast Growth Factor 2/pharmacology Fibroblasts/immunology,metabolism,pathology Humans Hypersensitivity, Immediate/immunology,metabolism,pathology Immune Sera/pharmacology Injections, Intradermal Interleukin-13/biosynthesis,pharmacology Intradermal Tests Male Middle Aged Muscle, Smooth/immunology,pathology RNA, Messenger/biosynthesis Skin/immunology,metabolism,pathology Tenascin/biosynthesis,genetics Transforming Growth Factor beta/biosynthesis,immunology,pharmacology Transforming Growth Factor beta1 Up-Regulation/immunology Wound Healing/immunology
Chemicals
Actins Allergens Biomarkers Immune Sera Interleukin-13 RNA, Messenger TGFB1 protein, human Tenascin Transforming Growth Factor beta Transforming Growth Factor beta1 Fibroblast Growth Factor 2
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Phipps Simon
Department of Allergy and Clinical Immunology, Faculty of Medicine, Imperial College, National Heart and Lung Institute, Dovehouse Street, London, UK, SW3 6LY.
Ying Sun
Wangoo Arun
Ong Yee-Ean
Levi-Schaffer Francesca
Kay A Barry
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
2002-10-15
Pages
4604-12
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com